ketamine with bupivacaine vs bupivacaine analgesia in breast surgeries
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/02/063084
- Lead Sponsor
- Jawahar Lal Nehru Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.females undergoing breast
cancer surgery.
2.ASA grade I and II.
Exclusion Criteria
1.Patient refusal.
2.Deranged coagulation profile.
3.History of opioid use or addiction.
4.Obesity
5.Pregnancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method duration of analgesiaTimepoint: immediate post operation baseline, 30mnts,1hr,2hr,4hr,6hr,12hr,24hr
- Secondary Outcome Measures
Name Time Method 1.Total postoperative analgesic consumption. <br/ ><br>2.Haemodynamic variable and side effectsTimepoint: immediate post operation baseline, 30mnts,1hr,2hr,4hr,6hr,12hr,24hr